Once- versus twice-weekly bortezomib induction therapy with CyBorD in newly diagnosed multiple myeloma
- PMID: 20413666
- DOI: 10.1182/blood-2010-02-271676
Once- versus twice-weekly bortezomib induction therapy with CyBorD in newly diagnosed multiple myeloma
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical